Related Experiment Video
Updated: Feb 26, 2026

Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria
Published on: February 23, 2014
Risk for Death among Children with Pneumonia, Afghanistan
Insights
Childhood pneumonia in Afghanistan is deadly, with high death rates in hospitalized children. Pneumococcal vaccination could significantly reduce these deaths, especially among vulnerable newborns and malnourished infants.
Area of Science:
- Pediatrics
- Infectious Diseases
- Public Health
Background:
- Childhood mortality due to pneumonia remains a significant public health concern in Afghanistan.
- High case-fatality rates underscore the urgent need for effective interventions.
Purpose of the Study:
- To assess the burden of childhood pneumonia and associated mortality in a hospital setting in Afghanistan.
- To evaluate the coverage of pneumococcal serotypes by the 13-valent vaccine and its potential impact.
Main Methods:
- Retrospective analysis of 639 pediatric cases hospitalized with pneumonia.
- Identification of pneumococcal serotypes from detected samples.
- Analysis of mortality rates and time to death post-hospitalization.
Main Results:
- The case-fatality rate for childhood pneumonia was 12.1% among the studied cohort.
- Nearly half (46.8%) of detected pneumococcal serotypes were covered by the 13-valent vaccine.
- A majority of deaths occurred within 48 hours of admission, with newborns and malnourished children identified as high-risk groups.
Conclusions:
- Childhood pneumonia poses a severe threat in Afghanistan, necessitating targeted public health strategies.
- The 13-valent pneumococcal vaccine shows potential for reducing disease burden and mortality.
- Timely interventions and vaccination are crucial for improving outcomes in vulnerable pediatric populations.
Abstract:
In Afghanistan, childhood deaths from pneumonia are high. Among 639 children at 1 hospital, the case-fatality rate was 12.1%, and 46.8% of pneumococcal serotypes detected were covered by the 13-valent vaccine. Most deaths occurred within 2 days of hospitalization; newborns and malnourished children were at risk. Vaccination could reduce pneumonia and deaths.
More Related Videos
05:50International Expert Consensus and Recommendations for Neonatal Pneumothorax Ultrasound Diagnosis and Ultrasound-guided Thoracentesis Procedure
Published on: March 12, 2020
04:32Murine Oropharyngeal Aspiration Model of Ventilator-associated and Hospital-acquired Bacterial Pneumonia
Published on: June 28, 2018
Related Concept Videos
Pneumonia I: Introduction
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Pneumonia III: Complications and Assessment
Pneumonia V: Nursing management and Prevention
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed....
Pneumothorax-I
Pneumothorax can be even further classified as spontaneous, traumatic, and tension pneumothorax.
Pneumonia IV: Management
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
Pneumonia II: Pathophysiology